
Taryn Eubank
@taryneubank
PharmD @HUPharmacy 💊 PGY2 ID @MethodistHosp 🦠 T32 ID Postdoctoral Research Fellowship @TheGareyLab 🧫 Research Assistant Professor @UH_Pharmacy
ID: 492698016
15-02-2012 01:03:48
875 Tweet
453 Followers
697 Following



Dr. Taryn Eubank study on the link between vancomycin susceptibility and decreasing sustained clinical response in C difficile infections #CDI contagionlive.com/view/insights-…



.Taryn Eubank The Garey Lab presented follow-up data at a meeting showing the novel antibiotic #ibezapolstat demonstrated favorable gut microbiome changes including increased relative proportion of Actinobacteria in ibezapolstat-treated patients with #Cdiff contagionlive.com/view/investiga…



We had a great Lab Retreat last week! Community service at the Houston Food Bank then headed on to more fun with lunch and mini golf! ⛳️



Very excited about this one accepted to Open Forum Infectious Diseases! Please take a read! #cdiff #IDtwitter

Dr. Taryn Eubank from UH Pharmacy elaborates on her findings that ribotype RT 027 is a risk factor for reduced vancomycin susceptibility in C diff infections. #CDI Read more: contagionlive.com/view/identifyi…




Check out the latest edition of SIDP & Contagion Live's Bench to Bedside Series focused on Echinocandin dosing in obesity from experts, Drs. Taryn Eubank and @DHPharmD! Read here: buff.ly/3ZlSPHe



Why are proton pump inhibitors associated with increased infection risk?? 🤔That's what we asked!! Check out Josef Fowler systematic review on PPI impact on macrophage and neutrophil function here: frontiersin.org/articles/10.33….

Next up at poster #74, 3rd year pharmacy student Megan Huang Frazier will be presenting her findings from her systematic review exploring clinical benefit of utilizing 125mg vs 250mg PO Vanc for CDI🦠Stop by and show her support! #GCCAMR2025 UH Pharmacy


Exciting Phase 2b results out now in The Lancet Microbe for ibezapolstat! Check it out! 👏🏻 ⬇️ sciencedirect.com/science/articl…
